Deborah Layton

Summary

Affiliation: Drug Safety Research Unit
Country: UK

Publications

  1. request reprint
    Layton D, Coughtrie A, Qayum N, Shakir S. Pattern of Onset and Risk Factors for Peripheral Oedema During Vildagliptin Use: Analysis from the Vildagliptin Prescription-Event Monitoring Study in England. Drug Saf. 2016;39:1093-1104 pubmed
    ..The observation that concomitant use of a sulfonylurea may also increase PO risk early after starting treatment should be taken into consideration if prescribing OADs in combination with vildagliptin. ..

Detail Information

Publications1

  1. request reprint
    Layton D, Coughtrie A, Qayum N, Shakir S. Pattern of Onset and Risk Factors for Peripheral Oedema During Vildagliptin Use: Analysis from the Vildagliptin Prescription-Event Monitoring Study in England. Drug Saf. 2016;39:1093-1104 pubmed
    ..The observation that concomitant use of a sulfonylurea may also increase PO risk early after starting treatment should be taken into consideration if prescribing OADs in combination with vildagliptin. ..